Clinical Trials Logo

Filter by:
NCT ID: NCT01142713 Not yet recruiting - Rectal Cancer Clinical Trials

The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study

Start date: August 2010
Phase: Phase 2
Study type: Interventional

Radiotherapy has a significant impact on local control, disease free survival and overall survival in patients with rectal cancer T2, N1, M0 and T3-4, any N, M0. Treatment is accompanied by side effects, mainly due to the inclusion of the small bowel and urinary bladder in the treatment fields. Two major modalities have been pursued to reduce the volume of small intestine and urinary bladder in treatment volume. One is a surgical procedure, such as absorbable mesh. These procedures have failed implementation in daily clinical practice. The second modality aims to save the small intestine and urinary bladder from the toxicity of radiotherapy by modulating the radiotherapy planning procedure. Using the belly board and changing the standard position from supine to prone could achieve this aim; in part due to gravitational displacement of the bowel. Several studies have evaluated the impact of positioning and use of belly board in patients receiving pelvis irradiation for rectal cancer. The results are inconclusive, but the prone position with belly board appears promising. This study carefully evaluates the impact of patient's positioning and belly board on dose volume histogram of small bowel and urinary bladder

NCT ID: NCT01143168 Not yet recruiting - Clinical trials for Type 1 Diabetes Mellitus

Stem Cell Therapy for Type 1 Diabetes Mellitus

Start date: August 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the feasibility, efficacy and safety of transplantation therapy using bone marrow mononuclear cells and umbilical cord mesenchymal stem cells for patients with type 1 diabetes mellitus

NCT ID: NCT01152983 Not yet recruiting - Healthy Clinical Trials

Safety and Performance Evaluation of the Rapid Ring Device

Start date: August 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to demonstrate the safety, performance and initial efficacy of the RapiDx device.

NCT ID: NCT01158040 Not yet recruiting - Clinical trials for Pregestational Diabetes

Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Observational Trial

Start date: August 2010
Phase: N/A
Study type: Observational

The purpose of this study is to compare intrapartum glycemic control using insulin pump versus intravenous (IV) insulin administration.

NCT ID: NCT01158846 Not yet recruiting - Clinical trials for ST-Elevation Myocardial Infarction

Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

Start date: August 2010
Phase: Phase 4
Study type: Interventional

In the setting of ST elevation myocardial infarction newer therapies has been recently studied and, following encouraging results, introduced into the clinical practice. Prasugrel showed to be a valid alternative to overcome limitation of clopidogrel therefore providing a better ischemic protection. On the other hand, bivalirudin is at least as beneficial as heparin/abciximab as anticoagulant agent but associated with fewer hemorrhagic events. The primary hypothesis of the study is that the combination of prasugrel plus bivalirudin can be associated with a better risk/benefit profile.

NCT ID: NCT01162057 Not yet recruiting - Hearing Clinical Trials

The Effect of Hemodialysis on Hearing

Start date: August 2010
Phase: N/A
Study type: Observational

The inner ear contains transporters that are responsible for maintaining a strict homeostatic environment, necessary for transmission and transduction of sound waves. Hemodialysis affects the body's composition including the aspects regulated by these transporters (pH, osmolarity, Na, K). We wish to observe if hemodialysis affects hearing, and if so, by which parameters.

NCT ID: NCT01163708 Not yet recruiting - Clinical trials for Osteoarthritis of the Knee

Prophecy Guide Outcomes in Total Knee Replacement Surgery

Start date: August 2010
Phase: Phase 4
Study type: Interventional

This project aims to assess two different techniques used to position the knee replacement implant during surgery. The patients will be randomised to receive either the following: 1. The established Navigation System (gold standard) 2. The new Prophecy Technique (validated by the Navigation System) The study hypothesis is there will be no difference between the gold standard Navigation system and the Prophecy technique in relation to the placement of the knee implant.

NCT ID: NCT01167205 Not yet recruiting - Healthy Clinical Trials

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

Start date: August 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether astaxanthin (ASX) supplementation will reduce obesity-induced oxidative stress and improve lipid profile in overweight and obese adults.

NCT ID: NCT01167413 Not yet recruiting - Fibromyalgia Clinical Trials

Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia

Start date: August 2010
Phase: N/A
Study type: Observational

Fibromyalgia Syndrome (FMS) is a non - inflammatory condition characterized by the presence of chronic, widespread musculoskeletal pain and tenderness; FMS is considered to be the result of increased processing of pain by the central nervous system. Axial spondyloarthropathy is the hallmark of Ankylosing Spondylitis (AS), an inflammatory joint disease involving the axial spine, the sacroiliac joints as well as peripheral joints. Although FMS and AS differ vastly in their pathogenesis, a considerable clinical overlap may exist between these conditions. Both disorders typically cause chronic nocturnal back pain and disturbed sleep may accompany either condition. In addition,the investigators have previously described an increased prevalence of (secondary) FMS among female AS patients. This overlap may have important clinical implications since the presence of comorbid FMS may lead to increased severity results on commonly used instruments in the evaluation of disease activity in AS, such as the BASDAI and BASFI . Recently, the Assessment of Spondyloarthritis international Society (ASAS) has published updated classification criteria for axial spondyloarthropathy. These criteria, which are summarized in table 1, are based on the evaluation of patients suffering from chronic back pain with an age of onset of less than 45. Objective: The objective of the current study is to evaluate the prevalence of axial spondyloarthropathies among FMS patients, utilizing the new ASAS criteria.

NCT ID: NCT01171443 Not yet recruiting - Multiple Myeloma Clinical Trials

The Pathophysiology of Bortezomib Induced Peripheral Neuropathy

BIPN
Start date: August 2010
Phase: N/A
Study type: Observational

Since the pathophysiology of BIPN still remains unclear, in the present study we are going to assess the development of BIPN in newly diagnosed myeloma patients, based on clinical neurological examination and electrophysiological study (EMG) and trying to find out if there is any relationship between oxidative stress generation measured by serum malonyldialdehyde - (MDA) and urinary isoprostane, and the development of BIPN, which can explain important part of the BIPN pathophysiology and can suggest new ideas of treatment and prophylactic strategies of peripheral neuropathy.